AKT1 and cancer: The phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) signalling pathway is hyperactivated or altered in many cancer types and increases expression of downstream targets contributing to anoikis resistance (reviewed in [25]).